(19)
(11) EP 4 511 507 A1

(12)

(43) Date of publication:
26.02.2025 Bulletin 2025/09

(21) Application number: 23889951.2

(22) Date of filing: 16.11.2023
(51) International Patent Classification (IPC): 
C12Q 1/6809(2018.01)
G01N 33/53(2006.01)
G16B 40/20(2019.01)
C12Q 1/6841(2018.01)
G16B 15/10(2019.01)
(52) Cooperative Patent Classification (CPC):
G16B 15/10; C12Q 1/6886; C12Q 2600/118; C12Q 2600/156
(86) International application number:
PCT/CA2023/051546
(87) International publication number:
WO 2024/103184 (23.05.2024 Gazette 2024/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 16.11.2022 WO PCT/CA2022/051694

(71) Applicant: Telo Genomics Holdings Corp.
Toronto, ON M5G 1L7 (CA)

(72) Inventors:
  • MAI, Sabine
    Winnipeg, Manitoba R3N 1M9 (CA)
  • LOUIS, Sherif
    Toronto, Ontario M5G 1L7 (CA)
  • KNECHT, Hans
    Magog, Québec J1X 6G3 (CA)

(74) Representative: Greaves Brewster LLP 
Copa House Station Road
Cheddar, Somerset BS27 3AH
Cheddar, Somerset BS27 3AH (GB)

   


(54) METHODS OF ASSESSING SMOLDERING MULTIPLE MYELOMA